Publication | Closed Access

Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors

UrologyCasomorphin PeptidesFunctional SelectivityMedicineOpioid AlkaloidsPharmacotherapyOpioid OverdosePartial InteractionProstatic DiseaseAnti-cancer AgentPharmacologyDrug Discovery